Loading company
Just reported
Q3 2026 results
From Medifast's results release of October 26, 2026; its quarterly report has since been filed.
Revenue
Actual
$72M
-19% y/y
-5.7% q/qGuided
$70M
midpoint
Within guide+2.9%EPS, GAAP
Actual
-$1.57
Guided
—
No guide given
Operating income, GAAP
Actual
-$19.4M
Guided
—
No guide given
Company outlook
Q4 2026
- Revenue$55M – $75M-13% y/y First given
Full year 2026
- EPS, adjusted$0.45 – $0.70First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Medifast is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Personal Services
Graded A or B and worth $2B or more: A first, then the largest.
SCIService Corporation International$10.3BA+
ANDGAndersen Group Inc.$7.4BA
ROLRollins, Inc.$18.4BB+
FTDRFrontdoor, Inc.$6.6BB+
HRBH&R Block, Inc.$6.3BB
Grade rose recently in Consumer Discretionary
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
TMToyota Motor Corp.Aug 4, 2026BAGraded B, now A
RCLRoyal Caribbean Cruises Ltd.Oct 27, 2026FBGraded F, now B
AZOAutoZone, Inc.Oct 26, 2026CBGraded C, now B
SWSmurfit Westrock plcOct 28, 2026CBGraded C, now B
HSAIHesai GroupNov 10, 2026CBGraded C, now B
Built from Medifast Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
